Substantial or rapid weight loss can increase the risk of cholelithiasis; however, the incidence of acute gallbladder disease was greater in WEGOVY-treated patients than in placebo-treated patients, even after accounting for the degree of weight loss. If cholelithiasis is suspected, gallbladder studie...
Wegovy Semaglutide Injection: Prescribing Information. Novo Nordisk, 2024. Bagsvaerd, Denmark. Available online: https://www.novo-pi.com/wegovy.pdf (accessed on 22 July 2024). Australian Government: Therapeutic Goods Administration. TGA Warns Advertising Prescription-Only Weight-Loss Medication Is Proh...